Clinical trial
Talc in Treating Patients With Malignant Pleural Effusion
NCT00002622 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002622 |
|---|---|
| Title | Talc in Treating Patients With Malignant Pleural Effusion |
| Official title | Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group Radiation Therapy Oncology Group North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Drug |
| Interventions | talc, Talc |
| Enrollment | 501 |
| Start date | Dec 1, 1994 |
| Primary completion | Mar 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Aug 31, 2004 |
| Last update posted | Jun 28, 2016 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: